FDA fills four senior roles, including top officials for drugs, vaccines and tobacco
The appointments give the agency permanent leaders for drugs, vaccines and tobacco while creating its first artificial intelligence and technology oversight post.
- On Tuesday, the Trump administration permanently filled four key FDA leadership roles, promoting officials to lead the agency's drug, vaccine, and tobacco centers, plus a new deputy commissioner for Artificial Intelligence.
- These appointments aim to stabilize the FDA following months of upheaval that saw high-profile departures earlier this year, including former Commissioner Marty Makary, vaccine director Vinay Prasad, and drug division leader Tracy Beth Hoeg.
- Prioritizing faster reviews for psychedelics like MDMA and LSD, the administration directed the agency to integrate Artificial Intelligence into its review processes under new leadership.
- Agency policy shifts in these centers have drawn significant scrutiny from Democrats in Congress, who question the department's handling of vaccines and expedited approval processes.
- The leadership changes also address the Center for Tobacco Products, which faced industry frustration over perceived lack of movement on flavored e-cigarettes, a key company priority.
24 Articles
24 Articles
Kennedy Names New Drug, Vaccine Chiefs to Lead FDA
Department of Health and Human Services (HHS) Secretary Robert Kennedy Jr. announced appointments for four top leaders overseeing vaccine approvals, new drug approvals, artificial intelligence (AI) innovations, and tobacco policy at the U.S. Food and Drug Administration (FDA) on Sept. 8 as the agency advances its health and wellness reforms. “We are building an FDA that moves faster, demands excellence, and delivers results for the American peop…
Associated Press News
FDA fills four senior roles, including top officials for drugs, vaccines and tobacco
The Trump administration named four officials to take over senior roles at the Food and Drug Administration, including the agency’s top leaders for drugs and vaccines.
U.S. Department of Health announces key leadership changes at FDA
Sept 8 (Reuters) - The U.S. Department of Health and Human Services on Tuesday named four senior leaders at the U.S. Food and Drug Administration, including the heads of its drug center and vaccines and biologics unit. (Reporting by ...
Coverage Details
Bias Distribution
- 45% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
